What is the role of rapid molecular testing for seniors and other at-risk adults with respiratory syncytial virus infections?
- 1 August 2019
- journal article
- review article
- Published by Elsevier in Journal of Clinical Virology
- Vol. 117, 27-32
Abstract
No abstract availableKeywords
Funding Information
- Janssen Pharmaceutica
This publication has 42 references indexed in Scilit:
- Point-Counterpoint: Large Multiplex PCR Panels Should Be First-Line Tests for Detection of Respiratory and Intestinal PathogensJournal of Clinical Microbiology, 2015
- Respiratory Syncytial Virus Infection in Older Adults: An Under-Recognized ProblemDrugs & Aging, 2015
- Clinical Outcomes Associated With Respiratory Virus Detection Before Allogeneic Hematopoietic Stem Cell TransplantClinical Infectious Diseases, 2015
- Impact of a Rapid Respiratory Panel Test on Patient OutcomesArchives of Pathology & Laboratory Medicine, 2014
- Better Tests, Better Care: Improved Diagnostics for Infectious DiseasesClinical Infectious Diseases, 2013
- Rates of Hospitalizations for Respiratory Syncytial Virus, Human Metapneumovirus, and Influenza Virus in Older AdultsThe Journal of Infectious Diseases, 2012
- Diagnosis of Respiratory Syncytial Virus InfectionThe Open Microbiology Journal, 2011
- Risk Factors for Respiratory Failure Associated with Respiratory Syncytial Virus Infection in AdultsThe Journal of Infectious Diseases, 2009
- Respiratory Syncytial Virus Infection in Elderly and High-Risk AdultsNew England Journal of Medicine, 2005
- Respiratory Syncytial Virus Pneumonia among the Elderly: An Assessment of Disease BurdenThe Journal of Infectious Diseases, 1999